Length heterogeneity at conserved sequence block 2 in human mitochondrial DNA acts as a rheostat for RNA polymerase POLRMT activity by Tan, Benedict G et al.
                          Tan, B. G., Wellesley, F. C., Savery, N. J., & Szczelkun, M. D. (2016).
Length heterogeneity at conserved sequence block 2 in human mitochondrial
DNA acts as a rheostat for RNA polymerase POLRMT activity. Nucleic
Acids Research, 44(16), 7817-7829. DOI: 10.1093/nar/gkw648
Publisher's PDF, also known as Version of record
License (if available):
CC BY
Link to published version (if available):
10.1093/nar/gkw648
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via Oxford University
Press at http://dx.doi.org/10.1093/nar/gkw648. Please refer to any applicable terms of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms.html
Nucleic Acids Research, 2016 1
doi: 10.1093/nar/gkw648
Length heterogeneity at conserved sequence block 2
in human mitochondrial DNA acts as a rheostat for
RNA polymerase POLRMT activity
Benedict G. Tan, Frederick C. Wellesley, Nigel J. Savery* and Mark D. Szczelkun*
DNA-Protein Interactions Unit, School of Biochemistry, University of Bristol, Bristol BS8 1TD, UK
Received June 10, 2016; Revised July 07, 2016; Accepted July 10, 2016
ABSTRACT
The guanine (G)-tract of conserved sequence block
2 (CSB 2) in human mitochondrial DNA can result
in transcription termination due to formation of a
hybrid G-quadruplex between the nascent RNA and
the nontemplate DNA strand. This structure can then
influence genome replication, stability and localiza-
tion. Here we surveyed the frequency of variation
in sequence identity and length at CSB 2 amongst
human mitochondrial genomes and used in vitro
transcription to assess the effects of this length
heterogeneity on the activity of the mitochondrial
RNA polymerase, POLRMT. In general, increased G-
tract length correlated with increased termination
levels. However, variation in the population favoured
CSB 2 sequences which produced efficient termina-
tion while particularly weak or strong signals were
avoided. For all variants examined, the 3′ end of
the transcripts mapped to the same downstream se-
quences and were prevented from terminating by ad-
dition of the transcription factor TEFM. We propose
that CSB 2 length heterogeneity allows variation in
the efficiency of transcription termination without af-
fecting the position of the products or the capacity
for regulation by TEFM.
INTRODUCTION
Human mitochondria contain multiple copies of a circu-
lar, double-strand mitochondrial DNA (mtDNA) genome
that encodes core proteins of the electron transport chain, as
well as tRNAs and rRNAs necessary for organelle-specific
translation. A distinctive feature of mtDNA replication is
that due to the absence of a dedicated mitochondrial pri-
mase, RNA primers for initiation of replication by DNA
polymerase  appear to be provided by the RNA poly-
merase, POLRMT (1–4). It has been suggested that these
primers arise from a switch in POLRMTactivity that causes
RNA transcripts to remain bound to the template as dis-
continuous but persistent RNA:DNA hybrids, termed ‘R-
loops’. At some locations, R-loopsmay be formed following
transcription of homopolymeric guanine (G)-tracts (5–8).
Guanine-stabilized R-loops appear to be widespread, also
being found in the nucleus, and play roles in DNA methy-
lation, histone modification, transcription, replication initi-
ation and immunoglobulin class-switch recombination (9–
11). Here, we investigated how naturally-occurring varia-
tions in the length of a specific G-tract can affect transcrip-
tion by human POLRMT.
Themechanism of humanmtDNA replication is not fully
understood and a number of conflicting models have been
proposed (12–16). Inmany of themodels, initiation of heavy
strand synthesis occurs at an origin (OH) found within an
∼1.1 kb intergenic non-coding region (NCR) (Figure 1).
(The two strands of mtDNA are termed heavy and light due
to different buoyant densities under centrifugal gradients).
The NCR also contains promoters for transcription of the
light strand or heavy strand (LSP orHSP, respectively). Full
length transcripts produced from the LSP or HSP are poly-
cistronic and are processed following transcription. How-
ever, LSP transcription events frequently terminate prema-
turely within the NCR at a series of Conserved Sequence
Blocks (CSB 3, CSB 2 and CSB 1; Figure 1). For exam-
ple, transcription of the adenine-interrupted, discontinuous
G-tract of CSB 2 leads to formation of a hybrid quadru-
plex between the RNA transcript and non-template DNA
that causes ‘premature termination’ of POLRMT (5–8).
This may then result in formation of R-loop structures that
provide free 3′ ends to prime subsequent DNA synthesis
(1,4,17–21). Preventing quadruplex formation reduces both
POLRMT premature termination and R-loop formation
(5,20). An intriguing recent observation is that the tran-
scription factor TEFM inhibits transcription termination
at CSB 2 by increasing the stability of the POLRMT elon-
gation complex, and thus may act to regulate R-loop for-
mation and handover between transcription and replication
machinery (22,23).
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Figure 1. The DNA sequence of the human mitochondrial NCR encom-
passing the light strand promoter and Conserved Sequence Blocks 1, 2 and
3. The control region of human mtDNA is indicated, with the locations of
LSP, HSP, OH, and HS1 and HS2 highlighted. The nucleotide from 211 to
450 of the revised Cambridge Reference Sequence (rCRS) (47), are shown,
with the locations of the LSP and of CSB 1, 2 and 3 highlighted (47). The
locations of the 3′ ends of the transcription products observed here are
shown (TP1, 2 and 3). We analysed length heterogeneity due to changes
to the G-tract between nucleotides 303–315, with the remainder of the se-
quence remaining the same.
mtDNA accumulates mutations much faster than nu-
clear DNA, leading to regions of hypervariable sequence
within the NCR (HS1 and HS2, Figure 1) and homopoly-
meric G-tracts are particular hot spots for sequence varia-
tion (24–26). Many studies have noted that CSB 2 (which
is part of HS2) can vary in the number of residues in the
first or second G-run of the discontinuous G-tract (25,27–
33). Such length heterogeneity can occur between individu-
als, between tissues of an individual, or even within single
cells, and has been used to designate human haplogroups
for studying evolution, genealogy, anthropology, and foren-
sics.Where variation occurs within one cell, tissue or organ-
ism (but not between individuals), this is sometimes alter-
natively referred to as ‘length heteroplasmy’. High levels of
length heterogeneity have been observed in hair follicle cells
and in oocytes, suggesting a role in rapidly dividing cells
(34–38). Differences have also been linked to some cancers
(39,40). Continuous G-tracts at CSB 2 are also observed,
where the central adenine residue has presumably been mu-
tated (28,41–44). However, there is sometimes ambiguity in
the definition of CSB 2 mutations [highlighted by (45)] and
it is unclear whether there is any global correlation between
variations in length of the first and second G-run. A better
understanding of the extent of CSB length heterogeneity in
the human population is important in interpreting the range
of possible effects on POLRMT transcription.
Most of the in vitro transcription studies with purified
proteins have usedmitochondrial DNA substrates based on
the revised Cambridge Reference Sequence (rCRS), where
the discontinuous CSB 2 sequence is five guanines followed
by seven guanines (G5AG7) (46,47) (Figure 1). However,
haplogroup studies observe that other variants are more
common, in particular those with six guanines in the first
run and seven to nine guanines in the second run. How
might such length heterogeneity affect the activity of POL-
RMT? In general terms, increasing the number of guanine
residues would be expected to increase quadruplex stabil-
ity. In agreement with this, (23) showed that a G6AG8
sequence increased transcription termination relative to a
shorter G5AG7 sequence. It has also been shown using the
bacteriophage T7 RNA polymerase, which is structurally-
related to POLRMT, that length increases in the second G-
run of discontinuous sequences (G6AG5 to G6AG15) or in
continuous sequences (G9 toG13) produces a general trend
of increased premature termination (43). However, it is still
not clear how the full range of human CSB 2 length hetero-
geneity would affect POLRMT in terms of the magnitude
and location of transcription termination.
To investigate the extent of length heterogeneity at CSB
2 sequences in human mtDNA, we surveyed sequences de-
posited in GenBank. We then used in vitro assays with pu-
rified recombinant human POLRMT to measure how the
distribution of observed length heterogeneity affected the
levels and location of transcription termination. We show
that while length heterogeneity of both discontinous and
continuous G-tracts can alter the amount of transcription
termination at CSB 2, it does not radically alter the 3′ posi-
tions of the resulting terminated transcripts. We also show
that the anti-termination effect of TEFM seen previously
(22,23) is insensitive to changes in sequence length or iden-
tity at CSB 2. We therefore propose that length heterogene-
ity can modulate the amount of transcription termination
at CSB 2 in a controllable manner without drastically af-
fecting the positioning of the termination products, in turn




Complete or partial human mitochondrial DNA sequences
were downloaded from GenBank by searching for ei-
ther complete human mitochondrial genomes (28 726
sequences) or partial human mitochondrial genome se-
quences that included the terms ‘control region’ or ‘hyper-
variable segment’ under ‘[All fields]’ (63 530 sequences). We
could not directly filter our search to include either ‘CSB’
or ‘Conserved Sequence Block’ as these terms are generally
not present in GenBank definitions or features. Therefore
many of the downloaded partial sequences did not include
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the region covering CSB 2––for example, they are sequences
of HS1 alone. The downloaded sequences were analysed
without further curation using prfectBLAST (48), a stan-
dalone version of BLAST (49). Sequences of bases corre-
sponding to the region 294–325 of the rCRS were used as
search strings (based on the minimum of 25 residues re-
quired for a search). Each string had varying numbers of
guanines in the first and/or second G-runs (between 1 and
12). Algorithmic parameters were set to ensure hits with
100% sequence identity: Maximum target sequence, 20 000;
expected threshold, 500; word size, 7; scoring, default; all
filters, off; nident; perc identity 100; num descriptions, 30
000; evalue, 0.001. This process was then repeated with the
search stringmodified so that the central adenine at 310 was
replaced by either cytosine, thymine or guanine. Sequences
that included CSB 2 but which varied from the search string
outside of the CSB2 G-tract (e.g. due to single nucleotide
mutations) would be overlooked by our search strategy.
Proteins
Human POLRMT with the mitochondrial signal pep-
tide removed (aa 41–1230, Supplementary Figure S1A)
was purified as an N-terminal His6 construct based on
(50). Human TFAM with the mitochondrial signal pep-
tide removed (aa 43–246, Supplementary Figure S1B)
was also purified as an N-terminal His6 construct us-
ing a similar protocol. Full-length human POLRMT
cDNA cloned into pBlueScriptR was obtained from
Geneservice Ltd (ID:5264127). The region encoding
residues 41–1230 was transferred into pET-DuetI (No-
vagen) using SacI and KpnI sites. Full length human
TFAM cDNA cloned into pCR4-topo was obtained
from Geneservice Ltd (ID:8992082). The region encoding
residues 43–246 was amplified using PCR primer pair
5′-GGAATTCCATATGTCATCTGTCTTGGCAGG-3′
and 5′-CCGCTCGAGTTAACACTCCTCAGCACC-3′
that placed an NdeI site upstream of the coding region
and an XhoI site downstream. The resulting PCR product
was inserted between the NdeI and XhoI sites of pET28a
(Novagen). To express POLRMT or TFAM, Escherichia
coli BL21(DE3) cells were transformed with the appro-
priate expression plasmid. Cultures were grown in LB at
37◦C. At an OD600 ∼0.5, expression was induced with
0.1 mM isopropyl--D-thiogalactopyranoside (IPTG)
for POLRMT, and 1 mM IPTG for TFAM, and cells
harvested after 4 and 1 h respectively. Cells were lysed
by sonication in 50 mM sodium phosphate, pH 8.0, 300
mM NaCl and 20 mM imidazole, plus protease inhibitor
(Roche complete, EDTA-free). Both proteins were purified
by affinity chromatography on a nickel Histrap HP column
(GE Healthcare), eluted via a 20–500 mM imidazole
gradient, followed by a Hitrap Heparin HP column (GE
Healthcare), eluted via a 0.15–1 MNaCl gradient. Proteins
were dialysed into storage buffer [POLRMT: 50 mM
sodium phosphate, pH 8.0, 50% (v/v) glycerol. TFAM:
10 mM Tris–Cl, pH 8.0, 1 mM DTT, 100 mM NaCl, 20%
(v/v) glycerol], concentrated by ultrafiltration, and stored
in aliquots at −80◦C.
Human TEFM with the mitochondrial signal peptide
removed (aa 36–360) was purified as a C-terminal His6
construct based on (22) (Supplementary Figure S1C). A
gene encoding TEFM 36–360, codon-optimized for E. coli
protein expression, was supplied by Eurofins (Supplemen-
tary Figure S1D), and cloned into the NdeI–XhoI sites
of pET24b to make pET24b-TEFM. E. coli BLR(DE3)
cells were transformed with pET24b-TEFM. Cultures were
grown in LB at 37◦C. At an OD600 ∼0.4, expression was
induced with 0.2 mM IPTG and cells were harvested af-
ter overnight incubation at 16◦C. Cells were lysed by son-
ication in lysis buffer [100 mM HEPES–HCl, 0.5 M NaCl,
10 mM imidazole, 10% (v/v) glycerol, 1 mM DTT, pH 7.5]
plus protease inhibitor (Roche complete, EDTA free) and
9 g/ml phenylmethane sulfonyl fluoride. His6-TEFM was
purified by affinity chromatography on a 5 ml Histrap HP
column (GE Healthcare), eluted via a 0.04–1 M Imidazole
gradient. Following dialysis against lysis buffer without im-
idazole but with 0.25 M NaCl added, the protein was fur-
ther purified using a 20 ml HiPrep Heparin 16/10 FF col-
umn (GEHealthcare), eluted via a 250–1MNaCl gradient.
Pooled His6-TEFM fractions were dialysed against stor-
age buffer (20 mM HEPES–HCl, 10% (v/v) glycerol, 300
mM NaCl, 2 mM DTT, pH 7.5), and subjected to an ad-
ditional size-exclusion chromatography step on a HiLoad
16/60 Sephadex S200 column. Pure TEFM was concen-
trated by ultrafiltration and stored in aliquots at −80◦C.
Purified human TFB2M (aa 31–396) was supplied by En-
zymax LLC. All other enzymes were fromNewEngland Bi-
olabs unless stated.
DNA substrates
All PCR reactions used PhusionDNAPolymerase (Thermo
Fisher Scientific). placCONS-Spe was generated from
placCONS (51) by inserting oligonucleotides containing a
SpeI site into the KpnI site (Supplementary Figure S2). The
NCR region (nucleotides 683–15 910) was PCR amplified
from mtDNA extracted from human RPE1 cells (a gift of
Jon Lane), using primers in Supplementary Figure S2, and
the product inserted into the SpeI site of placCONS-Spe.
The NCR sequence was converted into that of the rCRS
(47), using several rounds of site-directed QuikChange mu-
tagenesis (Agilent) with the primer pairs indicated in Sup-
plementary Figure S2, to make pGC-NCR(rCRS). G-tract
length heterogeneity mutations, as well as all other modifi-
cations to substrate sequences mentioned in this work, were
then introduced using inverse PCRwith the primer pairs in-
dicated in Supplementary Figures S3 and S4.
Linear DNA templates for transcription assays com-
prising nucleotides 509–16478 of the rCRS (102 bp
upstream and 500 bp downstream from the LSP) were
PCR amplified from the relevant plasmid using 5′-
GTAGGATGGGCGGGGGTTGTATTGATGAG-3′ and
5′-GCTAAAGTGAACTGTATCCGACATCTGGTTCCT-
3′. Impurities from the PCR reaction were removed using a
PCR cleanup kit (Qiagen).
Transcription assays
Prior to the addition of nucleotides, all reactions were set
up on ice. DNA templates were mixed with the appropriate
proteins inReaction Buffer (20mMTris–Cl, pH 8.0, 10mM
 at U
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MgCl2, 1mMDTT, 0.1% (v/v) Tween 20, 0.1mg/ml bovine
serum albumin (BSA)). Following 2 min pre-equilibration
at 35◦C, transcription was initiated by the addition of an
NTPmix. Final reaction conditions were 150 MGTP, 150
MCTP, 150 MATP, 10 MUTP, 0.033 M -32P-UTP
(3000 Ci/mmol), 12.5 nM DNA template, 50 nM POL-
RMT, 50 nMTFAM, 50 nMTFB2M, and, where indicated,
100 nM TEFMmonomer. Reactions were stopped after 30
min by the addition of 1/5 volume of stop buffer (0.1%
(w/v) sodium dodecyl sulphate (SDS), 150 mM ethylene-
diaminetetraaceticacid (EDTA), 0.4 mg/ml Proteinase K)
and incubated at 40◦C for 30 min. An equal volume of
loading dye (95% (w/v) formamide, 20 mM EDTA, 0.05%
(w/v) bromophenol blue and xylene cyanol FF, pH 8.0) was
added and the samples were boiled at 95◦C for 10 min fol-
lowed by a rapid quench on ice for 3 min prior to load-
ing on a TBE–urea gel (6% (w/v) acrylamide, 7 M urea, 90
mM Tris–borate, 2 mM EDTA). dsDNA markers for the
mini-gels (GeneRuler 50 bp DNA ladder, Thermo Fisher
Scientific) or for the sequencing gels (25 bp DNA ladder,
Invitrogen), were end-labelled using T4 polynucleotide ki-
nase and  -32P-ATP (3000 Ci/mmol) and unincorporated
nucleotides removed using Micro Bio-Spin 6 size-exclusion
columns (Bio-Rad). Markers were diluted 10-fold with Re-
action Buffer and prepared for electrophoresis as above for
the transcription reactions.
Sequencing gels (17 × 40 × 0.04 cm, SequiGen system,
Bio-Rad) were heated to 55◦C by pre-running at 65W (max
2 kV) for 1 h, whereas mini-gels (8.3 × 7.0 × 0.075 cm,
Mini-Protean, Bio-Rad) were pre-run at 200 V for 1 h with-
out temperature control. All gels were run in 90 mM Tris–
borate, pH 8.0, 2 mM EDTA, with temperature control at
55◦C for sequencing gels and without temperature control
at room temperature for mini-gels. Following electrophore-
sis, gels were fixed for 30 min in 10% (v/v) methanol, 10%
(v/v) acetic acid. Dried gels were exposed to a storage phos-
phor screen (Fujifilm), which was scanned using a Typhoon
phosphorimager (GE).
Data analysis
The 16-bit densitometric scans from the phosoimager were
analysed using the 1D gel analysis software of ImageQuant
(GE). All data graphs were produced and analysed us-
ing GraphPad Prism (GraphPad Software, Inc). For the
scanned data frommini-gels, the density of lane regions cor-
responding to CSB II-dependent transcription termination
products TP1, TP2, TP3 or TP (e.g. see Figure 2C) were
used to calculate termination efficiency as a percentage of
total lane density from the well to the ∼100 nt marker. The
mean and standard deviations were calculated from three
independent repeats. For the scanned data from sequenc-
ing gels, pixel position was converted to DNA length using
the parameters from a first order Lagrange curve fitted to
the 25 bp DNA ladder data. The density value of each pixel
within a lane was then normalized to the maximum pixel
density within the lane region that covered TP1-3 (92–140
nt). Skewness in Figure 2A was calculated using the SKEW
function of Microsoft Excel.
RESULTS
Length heterogeneity of CSB 2 in sequenced human mito-
chondrial genomes
To evaluate the sequence variation at CSB 2 in human mi-
tochondrial genomes, we examined sequences deposited in
GenBank. We compiled a database based on both com-
plete and partial human mtDNA sequences that included
the NCR, and analysed the data using nBLAST (48,49).We
first examined discontinuous sequences.We varied the num-
ber of guanines in each search string while keeping the cen-
tral residue as adenine (variations in the identity of this nu-
cleotide are considered in a later section). Our search algo-
rithm had a minimal text string size of 25 nucleotides, so we
used the rCRSup- and downstreamof theG-tracts.We used
the nomenclature GmAGn to classify our sequences, where
m and n are the number of guanines in the first and second
G-runs, respectively. Note that this is the reverse comple-
ment of the polyC-T-polyC sequence often quoted in hap-
logroup studies. The number of sequences found for each
variant are presented in matrix form in Figure 2A (45 197
sequences).
The majority of hits (>95%) cluster within a subset of se-
quences - the rCRS variant G5AG7 (13%), G6AG7 (37%),
G6AG8 (35%) and G6AG9 (10%) (Figure 2A). We note
that whilst the total length of these sequences varies be-
tween 12 and 15 guanines (Figure 2B), the first G-run is
always shorter than the second G-run. Many variants are
very low frequency (fewer than 20 hits). Some of these could
be false hits due to problems in accurate sequencing of G-
runs. However, we also note that other studies have reported
CSB 2 sequences that lie outside of the distributions seen
here––e.g. G6AG15, (37,43)––although these longer vari-
ants of the second G-run tend to always be found in studies
of hair cells. The data from these studies are not always de-
posited and are thus not part of the database.
In most cases, variation occurs by changes in the length
of just one of the two runs––i.e. most sequences occupy ei-
ther the column or the row in Figure 2A that bisect the
highest frequency sequenceG6AG7. The spread around the
G6AG7 variant is not symmetrical; in Figure 2A, >99% of
sequences occupy the top-right quadrant while the bottom-
left quadrant is under-occupied. This asymmetry is also re-
ported by the skewness values for the row and column to-
tals (Figure 2A). Overall, length heterogeneity appears to
disfavour first G-runs longer than six residues, in particular
when combined with second G-runs that are shorter than
five residues.
The effect of length heterogeneity on termination of POL-
RMT transcription
To assess how changes in the lengths of the first and second
G-runs of discontinuous CSB 2 sequences affect POLRMT
activity, we reconstituted transcription initiating from the
LSP in vitro using recombinant proteins and DNA.We pro-
duced a library of DNA substrates that contained a region
of the rCRS encompassing the LSP and CSB 3, 2 and 1
(nt 16 478-509) in which the number of guanine residues
in CSB 2 were varied. We chose to analyse each of the ‘oc-
cupied variants’ found in our database search (Figure 2A)
 at U
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Figure 2. Distribution of length heterogeneity in sequenced NCRs of human mtDNA and the effect on the levels of POLRMT transcription termination.
(A) Distribution of adenine-interrupted discontinuous CSB 2 G-tract hits from searches of complete and partial human mtDNA sequences deposited in
GenBank (total of 45 197). (B) Number of hits from panel A summed according to total number of guanine residues. (C) In vitro transcription assay. The
top panel cartoon shows the linear DNA substrate and the sizes of the run off (RO) and the three transcription products (TP1, TP2 or TP3) that can
appear due to CSB 2 (yellow box). The black box represents the TFAM binding site upstream of the light strand promoter (LSP). The lower panel shows
a representative mini-gel with the quantified percentage of total TP shown below each lane. The bands at the top of the gel are material retained in the
wells. (D) The average percentage of total TP (TP1 + TP2 + TP3) measured for different CSB 2 sequences (N = 3). The black lines show the extent of
sequences observed in panel A. Representative transcription mini-gels of all variants and bar graphs of the quantified data are shown in Supplementary
Figures S5 and S6. E. Cumulative correlation plot of occupied variants from panel A and average TP percentages for those variants from panel D. Most
of the occupied variants produced a total TP in vitro between 17% and 43%.
and, additionally, adjacent ‘unoccupied variants’ that dif-
fered by one or two nucleotides but which were not found in
the database search. Templates were produced by PCR and
mixed with POLRMT, TFAM and TFB2M under condi-
tions that allowedmulti-round transcription initiation from
LSP (seeMaterials andMethods). Transcripts were labelled
using incorporated radioactive UTP, and RNA products
from a single time point were separated on denaturing acry-
lamide mini-gels. Transcription from the LSP to the end of
the PCR template gave a run-off product (RO) of ∼500 nt
(Figure 2C). Transcription products (TPs) that accumulate
close to CSB 2 were ∼125 bp. TEFMwas excluded to show
the CSB 2-dependent product; the effect of TEFM is con-
sidered in a later section.
All of the CSB 2 variants were analysed in triplicate.
An example transcription gel for a range of substrates is
shown in Figure 2C. Representative gels for the complete
data set are presented in Supplementary Figure S5. In all
 at U
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cases, we observed bands corresponding to the RO and
TPs. Additional bands were also observed that represent
intermediate/termination products at other sequences un-
der our in vitro conditions. For all substrates, the TP re-
gion between ∼100–125 nt could be resolved into two dis-
tinct bands (TP1 and TP2, Figure 2C), similar to the prema-
ture termination products seen in other studies (5,6). With
some substrates an additional shorter transcription product
(TP3) could be resolved that has not been described previ-
ously (e.g. G7AG9, G7AG10 andG7AG11 Figure 2C). The
band intensity of the total TP region (encompassing TP1,
TP2 and TP3) relative to the complete lane (including other
intermediates and the RO) was quantified for each substrate
and is shown below the gel in Figure 2C (Materials and
Methods). In the absence of a G-tract, stalling driven by the
downstream poly-T tract alone is∼9% (quantified in Figure
6). We consider TP values above this basal value as show-
ing that the G-tract has increased termination at or close
to CSB 2. Because of the quantitation method, the values
here are considered as relative values to compare the effect
of length heterogeneity, rather than absolute values.
The mean TP total percentages for the complete dataset
are presented as a matrix heat map in Figure 2D. The
quantified data and statistical variation are shown in Sup-
plementary Figure S6. There was a general trend towards
increased TP levels as the as the total length of the G-
tract was increased, as one would predict from an increase
in quadruplex stability as more guanine tetrads can form
(52). In most cases only TP1 and TP2 bands were visi-
ble above background (Supplementary Figure S6B–D). The
TP3 band became visible above background with substrates
in the bottom-right quadrant as total TP levels increased to
43% or greater (Figure 2C, D and Supplementary Figure
S6D). The formation of TP3 is considered in Supplemen-
tary Figure S7. Variants that could generate TP3 were only
observed rarely in the database (20 out of 45 197), and this
product is unlikely to be relevant in vivo.
Is there a correlation between the frequency of occupied
variants found in the sequenced genome database (Figure
2A) and the corresponding TP levels observed in vitro (Fig-
ure 2D)? The majority of the occupied variants produced
TP levels of 17–43% (Figure 2E). Variants with 8–11 gua-
nines in total produced virtually no additional termina-
tion above the basal level and were correspondingly rarely
found in the database (only 40 occupied variants, Figure
2B). Similarly, variants that produced high levels of termi-
nation (>43%) were rarely found in the database. The rCRS
(G5AG7, Figure 1) produced a TP level half that of the
two most common sequences, G6AG7 and G6AG8 (Fig-
ure 2D). However, similar TP levels were seen with unoccu-
pied variants not found in the database (e.g. G7AG6, 17%),
while even lower TP levels were observed in some occu-
pied variants (e.g. G3AG9, 11%). It appears that TP levels
by themselves cannot explain why some sequences are pre-
ferred over others.
We noted that there was a marked asymmetry in the in
vitro transcription data in Figure 2D, with the relative po-
sition of the adenine residue being crucial to the observed
TP level rather than just the total number of guanines. This
is most clearly shown by grouping the data from Figure 2D
according to the total number of guanine residues and re-
Figure 3. The influence of the position of the adenine of discontinuous
CSB 2 sequences. (A) Definition of position of the middle adenine. Exam-
ples of G-tracts with even (G14) or odd (G13) numbers of guanines are
shown. See text for full details. (B) Percentage of TP as a function of posi-
tion of the adenine for discontinuous G-tracts of 9–17 residues. Data taken
from Figure 2D and Supplementary Figure S6 (N = 3, error bars S.D.).
(C) Data from Figure 2A plotted as a function of position of the adenine.
Colours represent the occupied variants with G-tract lengths as in panel
(B).
plotting the TP levels against the relative adenine position
(Figure 3A and B). Where the first G-run was longer than
the second G-run, the adenine was defined as having a pos-
itive position (i.e. towards the 3′ end of the G-tract). Where
the first G-run was shorter than the second G-run, the ade-
nine was defined as having a negative position (i.e. towards
the 5′ end of the G-tract). For sequences with an even num-
ber of total guanine residues, there can also be a zero po-
sition where the lengths of the two runs are identical. For
sequences with 11, 12, 13, 14, 15 or 17 guanines in total, the
highest TP levels were observed with adenines at the−1 po-
sition. For the sequences with 16 guanines, the highest TP
level was seen with the 0 position substrate.
Strikingly, ∼85% of the occupied variants from the se-
quenced genomes have the adenine at the −1 position (Fig-
ure 3C). Of these variants, almost all have 12–14 guanines,
where a 5′ or 3′ shift in the adenine position from −1
would produce a reduction in TP levels (Figure 3A). An-
other ∼13% of the occupied variants have sequences with
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Figure 4. Comparison of discontinuous and continuous CSB 2 sequences. (A) Distribution of continuous CSB 2G-tract hits from searches of complete and
partial humanmtDNA deposited in GenBank. (B) Representative mini-gel and the average percentage of total TP (N= 3, error bars S.D.) measured for the
discontinuous CSB 2 sequences G9AG6 (WT), G9TG6 (A>T) and G9CG6 (A>C), and the continuous CSB 2 sequence G16 (A>G). (C) Representative
mini-gel for transcription of discontinuous CSB 2 sequences G9 to G18. (D) The average percentage of total TP (N = 3, error bars S.D.) measured for the
continuous CSB 2 sequences G9 to G18, plotted as a function of total number of guanines alongside the discontinuous CSB 2 data from Figure 2D and
Supplementary Figure S6 grouped according to the position of the adenine as defined in the main text and Figure 3A. Error bars are omitted from the
discontinuous data for clarity.
a −2 adenine. Of these, over three quarters have 15 gua-
nines, where shifting from −1 to −2 produces only a small
effect (Figure 3A). Therefore, the majority of genomic dis-
continuous CSB 2 sequences have a structure that favours
the highest possible level of transcription termination given
the length of the G-tract.
The adenine residue that interrupts the G-tract of discontin-
uous CSB 2 sequences is not necessary for transcription ter-
mination
To investigate further the role of the interrupting adenine
residue, we searched the humanmtDNA sequences for CSB
2 variants where the adenine was replaced by either cytosine
or thymine, or was missing altogether, producing a contin-
uous G-tract. We found only two occurrences of a GmCGn
sequence [G10CG2 (53) and G5CG10 (54)] and only one
occurrence of a GmTGn sequence [G6TG8 (55)]. In con-
trast, continuous G-tracts were more frequent (1491 hits),
in particular G13 (Figure 4A).
To determine how changes to the central adenine residue
of CSB 2 affected transcription in vitro, we compared the TP
levels using DNA substrates where the adenine was substi-
tuted with thymine, cytosine or guanine. We chose to mod-
ify the G9AG6 variant as the adenine is in a relatively in-
efficient +2 position (Figure 3B), allowing us to determine
whether other bases enhanced or diminished formation of
TPs. The G9AG6, G9TG6 and G9CG6 sequences all gave
relatively similar TP levels (Figure 4B and C), suggesting
that adenine, thymine and cytosine all have the same effect
on transcription. In contrast, the G16 continuous sequence
produced amore than two-fold increase in TP levels (Figure
4B).
The efficiency of TP formation by the continuous se-
quences G9 to G18 was then examined (Figure 4C); TP lev-
els increased with G-tract length and only TP1 and TP2
were observed above background. The average quantified
TP levels for the continuous sequences are compared to the
values for the adenine-interrupted discontinuous sequences
in Figure 4D. For total G-tract lengths of 14 residues or
shorter, the continuous sequences were almost as efficient
as the best discontinuous sequence (i.e. adenine at the −1
position). For total G-tract lengths of 15 residues or longer,
there was less difference between the continuous G-tracts
and the discontinuous sequences with adenine at −2, −1, 0
or +1. The presence of an interrupting base pair is thus not
essential for efficient TP formation.
The CSB 2 termination sites are not affected by length het-
erogeneity
To identify the 3′ termini of the RNA products that accu-
mulate following transcription of CSB 2 and how these are
affected by length heterogeneity, we separated the in vitro
transcription reactions on larger denaturing ‘sequencing’
gels which give single nucleotide resolution (Supplementary
Figures S8 and S9). The gels were scanned for band inten-
sity and the data normalized to allow comparison of band
positions (Materials and Methods).
Figure 5A shows a comparison of scanned data for dis-
continuous CSB 2 variants where the first G-run was kept
constant at six residues (the most common value in Fig-
ure 2A) and the second G-run was varied between 2 and
11 residues. Residues downstream of the G-tracts were the
same in all cases and are numbered according to the rCRS
for ease of comparison (Figure 1) (47). Consistent with
previous studies, the main termination products (encom-
passing TP1) were located immediately downstream of, and
within, a T-tract (5′-T291TTTTT286-3′) (Figure 5A). For the
shorter variants G6AG2 to G6AG6, which produced basal
TP levels of 9–12%, the principal product terminated at
T283. As the second G-run increased in length from 7 to
11 residues, further products were observed between T283–
T288, with T284 eventually becoming the principal prod-
uct. TP2 transcripts terminated at positions 5′-T297GG295-
3′, and became more prominent as the total TP level in-
creased.
Figure 5B shows a comparison of scanned data for
discontinuous CSB 2 variants where the second G-run
was kept constant at seven residues (the most common
value––Figure 2A) and the first G-run was varied between
2 and 10 residues. Similar changes in the location of the
TP products were observed as those described above, ex-
cept that there were fewer products resulting from termina-
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Figure 5. Mapping the locations of transcription products as a function of length heterogeneity. (A) Varying the length of the secondG-run of discontinuous
sequences. (left panel) Denaturing sequencing gel showing the TP products from transcription reactions on DNA substrates where the first G-run was fixed
at six guanines and the second G-run was varied as shown (full gel in Supplementary Figure S9). Approximate positions of TP1, TP2 and TP3 are shown
(note that thesemove for each variant, as explained in Supplementary Figure S8. (right panel) Lanes from the gel were scanned and processed as described in
Materials andMethods to convert pixel position up the lane to a linear sequence scale (x-axis of graph) and to normalise the intensities so that themaximum
peak heights in each lane are the same (arbitrary y-axis of graph). Total TP percentages are shown in the brackets from Figure 2D and Supplementary
Figure S6 (N = 3, errors S.D.). To compare the positions of the TP bands, sequences were aligned using the 3′ terminal guanines of the G-tracts (black
vertical line). Sequences downstream of the G-tract are numbered according to the rCRS (47) (Figure 1). The uracil corresponding to transcription of
T284 is marked by the thick grey dotted line to help guide the eye. (B) Varying the length of the first G-run of discontinuous sequences. Transcription
reactions on DNA where the second G-run was fixed at seven guanines and the first G-run was varied as shown. Data treated as in panel A. Full gel in
Supplementary Figure S9. (C) Varying the length of continuous sequences. Transcription reactions on DNAwhere the length of continuous sequences was
varied as shown. Data treated as in panel A except that total TP percentages are from Figure 4D (N= 3, errors S.D.). Full gel in Supplementary Figure S9.
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tion upstreamofT284 and theTP2 products were less intense
(Figure 5B).
Figure 5C shows a comparison of scanned data for con-
tinuous CSB 2 variants. For G9 to G11, which gave basal
TP levels of ∼11%, the principal TP1 transcript terminated
at T283. As the continuous sequences were extended from
G12 to G18, a series of clearly-defined transcription prod-
ucts was observed between T288 to T282, with T284 becoming
the principal product from G14 upwards. TP2 bands were
less pronounced than with the discontinuous sequences, but
mapped to a similar location.
For all the CSB 2 sequences investigated, TP1 and TP2
mapped to similar locations: the TP1 products in the region
287–282; and the TP2 products in the region 297–295. In
both cases, there are T-tracts upstream of the 3′ ends of the
transcription products that will produce runs of uracils in
the transcript. Therefore, regardless of the identity of CSB2
or the level of termination produced, the 3′ ends of the tran-
scripts terminate at similar locations which appear to be in
proximity to T-tracts.
Role for the DNA sequence downstream of the G-tract in
transcription termination
To examine the relative influence of the CSB 2 G-tract se-
quence versus the T-tract sequences on formation of the
transcription products, we analysed a series of G5AG7 sub-
strates where the G-tract and/or the downstream sequences
were modified (Figure 6 and Supplementary Figure S10).
When the G-residues of G5AG7 were changed to
adenines (G>A), then the TP levels were reduced from
∼17% to ∼9% (Figure 6A), but the principal products still
mapped to T283/T284 (Figure 6B).We consider this to be the
basal level of transcription termination driven by theT-tract
alone for comparison with the data in Figure 2. We suggest
that on this substrate the elongation complex is destabilized
by the resulting poly rU•dA hybrid. Where we addition-
ally deleted the 5′-T291TTTTTGTT283-3′ sequence (G>A
TP), TP levels reduced further to ∼6% (Figure 6A) and
bands that could be resolved were more randomly-located
(Figure 6B).We consider this to be non-specific background
termination independent of either G-tract or T-tract se-
quences.
We then considered substrates where the G-tract region
was present but the downstream sequence was altered. We
deleted the 5′-T291TTTTTGTT283-3′ sequence alone (TP)
or mutated the 5′-T291TTTTT286-3′ sequence to to an A6-
run (A6). In both cases the TP levels were reduced from
∼17% to ∼10% (Figure 6A). Where alternate thymines of
the 5′-T291TTTTT286-3′ sequence were changed to cytosine
to strengthen the hybrid in the elongation complex [(UC)3],
the TP levels reducedmoremoderately from∼17% to∼13%
(Figure 6A). For A6 and (UC)3, the principal transcription
productsmapped to the same relative location as for theWT
sequence, ∼20 nt downstream of the G-tract (Figure 6B).
For TP a range of transcription products were observed
16–20 nt downstream of the G-tract (Figure 6B), and which
may reflect the presence of uracils in the hybrid.
This data suggests that the levels and locations of tran-
scription termination are due to the combined influence in
the transcript of the runs of guanine and uracil residues,
with polyU sequences acting as a termination signal in their
own right. To explore this further we produced substrates
with three nucleotides (AAA or CGT) inserted immediately
downstream of either a G9AG8 or G10AG7 sequence (Fig-
ure 6C). Insertion of either spacer shifted the TP2 and TP1
bands by exactly three nucleotides downstream whilst the
position of TP3 was unaffected. This shows that the loca-
tion of the transcription products is not wholly due to a
‘molecular ruler’ starting at the G-tract. We instead pro-
pose that TP1 and TP2 are influenced by: (i) the G-tract,
which causes varied product formation dependent upon its
sequence, within a region covering at least 16–23 nt down-
stream independent of its sequence; and, (ii) the presence
of thymine residues in the downstream region, in particu-
lar, but not exclusively, a poly T-run which both increases
product formation and locates the 3′ ends more precisely.
The transcription elongation factor TEFMreduces formation
of all transcription termination products at CSB 2 indepen-
dent of length heterogeneity
It has been demonstrated previously that TEFM can alle-
viate formation of transcription products within CSB 2 for
bothG5AG7 andG6AG8 sequences (22,23). Here we tested
the effect of TEFM on in vitro transcription using a range
of characteristic variants: G6AG7 (the most common se-
quence identified here); G10AG7 (a sequence that produces
TP3 and which has a longer first G-run); G6AG11 (a se-
quence with a longer second G-run that produces high TP
levels); and,G13 andG17 (continuous sequences producing
intermediate and high TP levels, and which represent ade-
nine deletion mutations of G6AG7 and G6AG11) (Figure
7). In all cases, TEFM reduced TP to close to basal levels
seen in the absence of a G-tract (see Figure 6A). All tran-
scription products were reduced, including the TP3 band
seen with G10AG7. Therefore, TEFM can regulate POL-
RMT transcription product formation at CSB 2 indepen-
dent of the exact sequence of the G-tract.
DISCUSSION
It has been suggested previously that formation of a hybrid
quadruplex at CSB 2 causes premature termination of tran-
scription by POLRMT (5–7). From our analysis of the hu-
man mtDNA sequences, there is clear evidence that CSB 2
varies in the number of residues in both the first and sec-
ond G-runs, although >84% of the changes are in the sec-
ond G-run of a G6AGn sequence, where N = 2–11 (Figure
2). As the total number of guanine residues was increased,
there was a general trend towards increased transcription
termination measured in vitro (Figure 2), as one would pre-
dict from an increase in quadruplex stability as more tetrads
form (52)). However, regardless of the variant investigated
in vitro, the 3′ ends of the terminated transcripts were lo-
cated at similar downstream sequences (Figure 5). This is
likely because of the influence of U-rich sequences in the
transcript (Figure 6), consistent with the previous sugges-
tion of a mechanism similar to rho-independent termina-
tion (22,23,56). We suggest that since variation in the num-
ber of guanine residues within CSB 2 produces changes in
the amount of transcription terminationwithout drastically
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Figure 6. The role of sequences downstream of the CSB 2 G-tract in transcription termination. (A) Representative mini-gel and the average percentage
of total TP (N = 3, error bars S.D.) measured for the discontinuous CSB 2 sequences G5AG7 (WT), and modifications to the G-tract (G>A) and/or the
downstream sequences [TP, A6 or (UC)3]. Details of the sequence changes are shown in panel (B) and described in themain text. (B) Transcription reactions
from panel A were also separated on a sequencing gel (Supplementary Figure S10) and the lanes scanned and processed as described in Figure 5. The 5′-
T291TTTTTGTT283-3′ sequence is highlighted in yellow. Sequences changes are highlighted in red. The sequence downstreamof the 5′-T291TTTTTGTT283-
3′ sequence is highlighted in blue to emphasise that it moves relative to the G-core sequence in theTP substrates. Percentages are the TP levels from panel
(A) (N = 3, errors S.D.). (C) The effect of a three nucleotide insertion on the position of the transcription products. (cartoon) The CSB 2 variants G9AG8
and G10AG7 were mutated by insertion of AAA or CGU nucleotides 3′ to the G-tracts. Transcription reactions were separated on a sequencing gel
(Supplementary Figure S10) and the lanes scanned and processed as described in Figure 5. Average percentages of total TP (N = 3, errors S.D.) were
calculated from mini gels (Supplementary Figure S10). The positions of the main TP2 and TP1 bands are shown by grey lines, with the shift produced by
the insertion mutations indicated by the blue arrows.
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Figure 7. The influence of length heterogeneity on the anti-termination ac-
tivity of the transcription factor TEFM. A representative mini-gel (A) and
the average percentage of total TP (N = 3, error bars S.D.). (B) measured
for the discontinuous CSB 2 sequences G6AG7, G10AG7 and G9AG11,
and the continuous CSB 2 sequences G13 and G17, in the absence and
presence of an equimolar concentration of TEFM dimer to POLRMT.
changing the location of the products, length heterogeneity
could be a mechanism to modulate the level of R-loop for-
mation and consequently downstream events such as initia-
tion of replication. TEFM was able to inhibit formation of
all transcription products at CSB 2 regardless of the identity
of theG-tract tested (Figure 7). Consequently, CSB 2 length
heterogeneity would not necessarily result in a loss of con-
trol of transcription termination within the NCR. This also
suggests that a mechanism to control TEFM activity would
be required.
Our analysis of the deposited genome sequences revealed
an asymmetric population distribution of discontinuous
CSB 2 variants (Figure 2). The majority of occupied vari-
ants had the characteristic adenine in an off-centre location
where the first G-run is one or two residues shorter than
the second run. This trend correlates with the most efficient
transcription product-forming sequences for a given num-
ber of guanines (Figure 3). When the adenine was placed
closer to the 5′ or 3′ ends of the G-tract, formation of CSB
2-dependent transcription products was reduced. We sug-
gest that in these CSB 2 sequences the adenine acts as a
quadruplex-breaking residue and that these variants are
avoided in the population by selection. This reduced effi-
ciency may be because the position of the adenine produces
a relatively short G-run at one or other end of the G-tract
that cannot participate in quadruplex formation; the num-
ber of tetrads is instead limited by the length of the longer
G-run. This effect isminimized or negatedwhen the adenine
is situated at a more central position where both G-runs
are of sufficient length to participate in tetrad formation.
The influence of the adenine position is less pronounced for
longer discontinuous G-tracts, possibly because the longer
G-run becomes equivalent to a more stable continuous G-
tract (Figures 3 and 4). For short discontinuous sequences
(9–11 guanine residues), where termination is near the basal
level, there is little effect of the position of the adenine, pos-
sibly as quadruplex structures are not forming to any great
extent.
Discontinuous CSB 2 sequences where the adenine is re-
placed with thymine or cytosine were virtually absent from
the sequenced genomes, despite the fact that these residues
produced the same quadruplex-breaking effect (Figure 4).
Conversely, continuous sequences were more frequent rel-
atively (Figure 4), were almost as efficient at transcription
termination in vitro as the best discontinuous sequence (Fig-
ure 4), produced transcripts that mapped to the same down-
stream T-rich locations (Figure 5), and could be regulated
by TEFM (Figure 7). Continuous sequences could arise due
to mutation of the adenine residue by either transition or
deletion, and are regularly reported as by-products of ele-
vated length heterogeneity (28,41–44). The loss of the ade-
nine residue would not necessarily alter the ability to con-
trol termination at CSB 2, and could in some instances re-
move an adenine from an unfavourable position. Nonethe-
less, the −1 discontinuous sequences remained the most ef-
ficient. When located at the −1 position, the adenine may
favour formation of particularly stable quadruplex struc-
tures. However, it is unlikely that the adenine plays a special
structural role. Instead the rarity of mutation of the adenine
to thymine or cytosine most likely reflects the fact that tran-
sitionmutation is a rare event compared to adenine deletion
by elevated levels of polymerase slippage at CSB 2 (see be-
low).
In addition to modulating quadruplex stability, CSB 2
length heterogeneity may result in increased heterogeneity
in quadruplex structure (52). Longer sequences may also
allow quadruplexes to seed in different registers; for exam-
ple, there is evidence for an increased number of distinct
transcription products upstream of T284 for the G12–G18
continuous sequences in Figure 5C. Notwithstanding the
possible presence of a continuum of alternate structures, we
observed that the transcription products always terminated
close to the downstream T-rich sequences. This emphasises
the importance of this genomic region as part of CSB 2.
Because of the potential for heterogeneity in quadruplex
structures resulting from length heterogeneity, we would ar-
gue that TEFM does not assist POLRMT by making spe-
cific interactions with a unique CSB 2 quadruplex structure,
but instead through a general stabilization of the elongation
complex that allows bypass of alternative structures.
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If CSB 2 length heterogeneity allows for changes in the ef-
ficiency of transcription termination and stable R-loop for-
mation, this may in turn allow for changes in the amount
of initiation of DNA replication. Thus length heterogene-
ity could also influence mtDNA copy number, or alter D-
loop structures that can play diverse roles in, for exam-
ple, nucleoid localization or genome stability. What then
causes hypervariation at CSB 2? Length changes in the G-
tract are most likely due to slippage during replication (57).
Genetic drift in the G-tract length may be driven by the
mechanism of mutation during replication or alternatively
by selective pressures that favour sequences that produce
more transcription termination under conditions that re-
quire higher levels ofmtDNAreplication.As noted byClay-
ton (25,26), it is not clear why the secondG-run should pro-
duce more replication slippage, and thus mutation, than the
first G-run, or why other homopolymeric G-tracts found in
mtDNA are not hypervariable. One answer might be that
when mtDNA replication needs to be elevated, this requires
more initiation events in the proximity of CSB2 and it is
the initiation process itself that cause the mutations to arise
principally in the secondG-run. It is interesting to note that
increased length heterogeneity has been reported in cells
with elevated growth characteristics. Increased replication
initiation could also lead to loss of the adenine by replica-
tion slippage, leading to the appearance of continuous se-
quences. The guanine-rich sequence of CSB 2 may be a hot
spot for mutation by virtue of being a hot spot for replica-
tion initiation.
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